Status:
RECRUITING
French Parkinson's Disease Cohort - NS-PARK
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Parkinson Disease
Eligibility:
All Genders
10+ years
Brief Summary
The aim of NS-PARK cohort are to describe the natural history of Parkinson's disease (PD), and to propose patients stratification models based on PD pathophysiological mechanisms. Patients are include...
Detailed Description
The national clinical research network for Parkinson's disease (NS-PARK/FCRIN) reassembles all expert centers in Parkinson's disease (PD) in France. Its aim is to promote clinical research in Parkinso...
Eligibility Criteria
Inclusion
- Diagnosis of Parkinson's disease according to UK PD brain bak criteria
- OR diagnosis of parkinsonian syndrome: multiple system atrophy, progressive supranuclear palsy, dementia with Lewy body, or corticobasal syndrom
- OR Subjects at risk of PD defined as :
- No symptom or diagnosis of Parkinson's disease nor parkinsonian syndrome, and relative to a patient with a diagosis of PD or parkinsonian syndrome, or carrier of a known mutation responsible for a genetic form of PD or patient with a diagnosis of idiopathic REEM sleep disorder or prodromal form of PD as defined by MDS criteria (Berg et al., 2015)
- AND for all participants
- Affiliated to social security
- Age \> 10 years
Exclusion
- Subject under legal protection
- Subject who do not consent to the research
- for the optional skin biopsy only: clinically significant coagulation abnormalities or anticoagulant treatment
Key Trial Info
Start Date :
June 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2030
Estimated Enrollment :
30000 Patients enrolled
Trial Details
Trial ID
NCT04888364
Start Date
June 16 2021
End Date
June 30 2030
Last Update
January 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre 01 Paris
Paris, France, 75013